Cooley Advises Jazz Pharmaceuticals in Acquisition of ADX-N05

Palo Alto, Calif. – January 23, 2014 – Cooley LLP announced today that it represented Jazz Pharmaceuticals plc in its $125 million acquisition of the worldwide development, manufacturing and commercial rights to ADX-N05 from Aerial BioPharma, LLC. ADX-N05 is being developed for the treatment of excessive daytime sleepiness in patients suffering from narcolepsy.

The Cooley team representing Jazz included partner Marya Postner and associates Bin Wang and Holly Holloway (life sciences); partner Chadwick Mills (capital markets); partners Bill Morrow and Mark Windfeld-Hansen (tax); partners Mischi a Marca and Michael Tollini and associates Amanda Fant and Jason Savich (credit finance); partner Francis Fryscak (antitrust); partner Natasha Leskovsek (health care & life sciences regulatory); and partner Gregory Tenhoff and associate Tyler Onitsuka (employment).

View the company press release here.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.